SOPHiA GENETICS (SOPH) EBIAT (2020 - 2025)
Historic EBIAT for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to -$20.0 million.
- SOPHiA GENETICS's EBIAT fell 858.55% to -$20.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$75.0 million, marking a year-over-year decrease of 501.86%. This contributed to the annual value of -$62.5 million for FY2024, which is 2087.59% up from last year.
- As of Q3 2025, SOPHiA GENETICS's EBIAT stood at -$20.0 million, which was down 858.55% from -$22.4 million recorded in Q2 2025.
- In the past 5 years, SOPHiA GENETICS's EBIAT registered a high of -$12.7 million during Q1 2021, and its lowest value of -$25.5 million during Q1 2022.
- Its 5-year average for EBIAT is -$19.1 million, with a median of -$19.7 million in 2023.
- Data for SOPHiA GENETICS's EBIAT shows a peak YoY increase of 9979.7% (in 2021) and a maximum YoY decrease of 10393.09% (in 2021) over the last 5 years.
- SOPHiA GENETICS's EBIAT (Quarter) stood at -$21.4 million in 2021, then surged by 34.64% to -$14.0 million in 2022, then tumbled by 72.21% to -$24.1 million in 2023, then surged by 37.0% to -$15.2 million in 2024, then plummeted by 32.08% to -$20.0 million in 2025.
- Its last three reported values are -$20.0 million in Q3 2025, -$22.4 million for Q2 2025, and -$17.4 million during Q1 2025.